HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Permissions Request Permissions Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (3) Citing Articles via Google Scholar Google Scholar Articles by Moorcroft, A. J. Articles by Webb, A. K. Search for Related Content PubMed PubMed Citation Articles by Moorcroft, A. J. Articles by Webb, A. K.

Symptoms, lactate and exercise limitation at peak cycle ergometry in adults with cystic fibrosis

¹ The Royal Shrewsbury Hospital, Shrewsbury, and ² Manchester Adult CF Centre, and ³ Dept of Medical Statistics, South Manchester University Hospitals NHS Trust, Wythenshawe Hospital, Manchester, UK

CORRESPONDENCE: A. K. Webb, Manchester Adult Cystic Fibrosis Centre, Wythenshawe Hospital, South Manchester, M23 9LT, UK. Fax: 44 1612912080. E-mail: the5webbs@hotmail.com

Keywords: Cystic fibrosis, dyspnoea, exercise, lactate, muscle effort, symptom limitation

Received: January 27, 2004
Accepted February 3, 2005

The purpose of this study was to investigate symptoms, lactate accumulation and limiting factors at peak exercise in cystic fibrosis (CF) patients.

In total, 104 CF adults attending an adult CF centre and 27 controls performed progressive cycle ergometry to a symptom-limited maximum. Measurements taken at peak exercise included: heart rate, ventilation, oxygen uptake, carbon dioxide output, oxygen saturation and blood lactate. Symptom scores of perceived breathlessness and muscle effort were recorded using Borg scales.

The CF subjects had a lower mean body mass index, forced expiratory volume in one second (FEV₁) and peak oxygen uptake than controls. Peak lactate concentrations were very similar to controls (mean±SD 6.8±2.0 mmol·L^–1 versus 7.4±1.0 mmol·L^–1). Symptom scores were no different to controls for either breathlessness (4.5±2.0 versus 4.3±1.0) or perceived muscle effort (6.1±2.0 versus 6.5±1.0), with higher scores for muscle effort than breathlessness in both groups. In addition, peak ventilation was lower than the predicted maximum, and high peak heart rates were recorded supporting nonpulmonary factors as important in limiting peak exercise. Peak oxygen uptake was correlated with FEV₁.

Comparison of CF subjects with mild or moderate pulmonary disease and controls revealed similar exercise responses. In contrast, those CF patients with severe lung disease (FEV₁ <40% predicted) had significantly higher breathlessness, lower muscle effort scores, lower peak lactate, lower peak heart rate and a mean ventilation exceeding predicted, thus confirming that ventilation was the major factor limiting exercise.

In conclusion, cystic fibrosis subjects have a reduced peak exercise capacity, but their exercise response is similar to controls in generating high blood-lactate concentrations and symptoms of muscle effort in excess of dyspnoea. Nonpulmonary factors influence peak performance more in those without severe disease.

This article has been cited by other articles:

				D. Hubert, F. Aubourg, B. Fauroux, L. Trinquart, I. Sermet, G. Lenoir, A. Clement, A. T. Dinh-Xuan, B. Louis, B. Mahut, et al. Exhaled nitric oxide in cystic fibrosis: relationships with airway and lung vascular impairments Eur. Respir. J., July 1, 2009; 34(1): 117 - 124. [Abstract] [Full Text] [PDF]

				D. J. Samuvel, K. P. Sundararaj, A. Nareika, M. F. Lopes-Virella, and Y. Huang Lactate Boosts TLR4 Signaling and NF-{kappa}B Pathway-Mediated Gene Transcription in Macrophages via Monocarboxylate Transporters and MD-2 Up-Regulation J. Immunol., February 15, 2009; 182(4): 2476 - 2484. [Abstract] [Full Text] [PDF]